GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shandong Weigao Group Medical Polymer Co Ltd (OTCPK:SHWGY) » Definitions » PE Ratio without NRI
中文

Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) PE Ratio without NRI

: 9.90 (As of Today)
View and export this data going back to 2011. Start your Free Trial

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2024-04-24), Shandong Weigao Group Medical Polymer Co's share price is $2.445. Shandong Weigao Group Medical Polymer Co's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2023 was $0.25. Therefore, Shandong Weigao Group Medical Polymer Co's PE Ratio without NRI for today is 9.90.

During the past 13 years, Shandong Weigao Group Medical Polymer Co's highest PE Ratio without NRI was 45.56. The lowest was 6.62. And the median was 20.74.

Shandong Weigao Group Medical Polymer Co's EPS without NRI for the six months ended in Jun. 2023 was $0.15. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2023 was $0.25.

As of today (2024-04-24), Shandong Weigao Group Medical Polymer Co's share price is $2.445. Shandong Weigao Group Medical Polymer Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $0.25. Therefore, Shandong Weigao Group Medical Polymer Co's PE Ratio for today is 9.94.

Good Sign:

Shandong Weigao Group Medical Polymer Co Ltd stock PE Ratio (=7.1) is close to 10-year low of 6.73

During the past years, Shandong Weigao Group Medical Polymer Co's highest PE Ratio was 89.39. The lowest was 6.73. And the median was 19.64.

Shandong Weigao Group Medical Polymer Co's EPS (Diluted) for the six months ended in Jun. 2023 was $0.15. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $0.25.

Shandong Weigao Group Medical Polymer Co's EPS (Basic) for the six months ended in Jun. 2023 was $0.15. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2023 was $0.25.


Shandong Weigao Group Medical Polymer Co PE Ratio without NRI Historical Data

The historical data trend for Shandong Weigao Group Medical Polymer Co's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Weigao Group Medical Polymer Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PE Ratio without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.22 33.72 14.31 18.83 15.34

Shandong Weigao Group Medical Polymer Co Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.31 At Loss 18.83 At Loss At Loss

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Shandong Weigao Group Medical Polymer Co's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Weigao Group Medical Polymer Co PE Ratio without NRI Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Shandong Weigao Group Medical Polymer Co's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Shandong Weigao Group Medical Polymer Co's PE Ratio without NRI falls into.



Shandong Weigao Group Medical Polymer Co PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

Shandong Weigao Group Medical Polymer Co's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=2.445/0.247
=9.9

Shandong Weigao Group Medical Polymer Co's Share Price of today is $2.445.
For company reported semi-annually, Shandong Weigao Group Medical Polymer Co's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.25.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Shandong Weigao Group Medical Polymer Co  (OTCPK:SHWGY) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


Shandong Weigao Group Medical Polymer Co PE Ratio without NRI Related Terms

Thank you for viewing the detailed overview of Shandong Weigao Group Medical Polymer Co's PE Ratio without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Business Description

Traded in Other Exchanges
Address
No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.

Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Headlines